Wednesday Mar 5
Barclays Initiates Coverage on Cardinal Health
Barclays analyst Eric Percher began coverage on the US Health Care Distribution and Tech industry Wednesday morning, including coverage initiation on Cardinal Health with an Overweight rating and price target of $79.
KEW Group Inc. Announces Completion of Private Financing Round
KEW Group Inc. , a privately held oncology services company located in Cambridge, Mass., announced today the recent closing of a private round of financing with Cardinal Health and The Bolyston Street Group.
The Columbus Dispatch
Investments seek to grow cybersecurity jobs in central Ohio
"The Collaboratory is a promising opportunity to showcase the strengths of the central Ohio business community," said Martin Inglis, Battelle executive vice president and COO.
Cardinal Health Downgraded to "Sell" at Jefferson Research
Cardinal Health traded up 0.19% on Friday, hitting $70.051. 368,970 shares of the company's stock traded hands.
Corporate titans' Columbus Collaboratory data co-op lands $5M in state Third Frontier funding
Several Columbus corporations are banding together on the Columbus Collaboratory to develop corporate solutions for data analytics and cyber security.
RPT-Fitch Affirms Cardinal Health at 'BBB+'; Outlook Stable
Fitch Ratings has affirmed the ratings of Cardinal Health, Inc. , including the long-term Issuer Default Rating , at 'BBB+'.
West Virginia AG focus of attention for accepting Cardinal Health donations during state lawsuit
West Virginia Attorney General Patrick Morrisey has been accepting campaign contributions from Cardinal Health Inc. while his office is suing the Dublin company.
Weekly CFO Sells Highlight: Facebook Inc., Cardinal Health Inc., Alexion Pharmaceuticals Inc. ...
According to GuruFocus Insider Data , the recent CFO sales were: Facebook Inc., Cardinal Health Inc., Alexion Pharmaceuticals Inc. and Thermo Fisher Scientific Inc. On 02/05/2014, CFO David A. Ebersman sold 23,400 shares at an average price of $62.36.
Cardinal Health Inc - 10-Q - : Management's Discussion and Analysis...
The discussion and analysis presented below is concerned with material changes in financial condition and results of operations for our condensed consolidated balance sheets at December 31, 2013 and June 30, 2013 , and for our condensed consolidated statements of earnings for the three and six months ended December 31, 2013 and 2012.